January 28, 2015 1:51 AM ET

Biotechnology

Company Overview of OvaScience, Inc.

Company Overview

OvaScience, Inc., a life sciences company, is engaged in the discovery, development, and commercialization of new treatments for infertility. The company’s patented technology is based on the discovery of egg precursor cells (EggPCs), which are found in the ovaries. It is developing various fertility treatment options designed to enhance egg quality and in vitro fertilization (IVF) comprising AUGMENT to improve egg quality and increase the success of IVF by transferring mitochondria from a woman's EggPCs to her mature egg during IVF; OvaPrime for boosting a woman's egg reserve by transferring the EggPCs from the outer layer of her ovary back into the ovary prior to IVF; OvaTure to create mat...

215 First Street

Suite 240

Cambridge, MA 02142

United States

Founded in 2011

28 Employees

Phone:

617-500-2802

Key Executives for OvaScience, Inc.

Co-Founder
Age: 38
President
Total Annual Compensation: $106.3K
Compensation as of Fiscal Year 2013.

OvaScience, Inc. Key Developments

OvaScience, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 03:30 PM

OvaScience, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 03:30 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Michelle Dipp, Co-Founder, Chief Executive Officer and Director.

OvaScience, Inc. Announces Resignation of Stephen Kraus from Board of Directors and the Compensation Committee and the Nominating and Corporate Governance Committee

On December 23, 2014, Stephen Kraus resigned from the OvaScience, Inc. Board of Directors and the Compensation Committee and the Nominating and Corporate Governance Committee of the Board of Directors. His resignation was not the result of a disagreement on any matter related to the company's operations, policies or practices.

OvaScience, Inc. Announces Executive Changes

OvaScience, Inc. promoted chief scientific officer Arthur Tzianabos to president, succeeding Michelle Dipp, who will continue to serve as CEO under an extended employment contract. The company also appointed David Harding as chief commercial officer. Previously, Harding held various positions at Hologic Inc. (HOLX), most recently as senior vice president and general manager of the company's women's health division.

Similar Private Companies By Industry

Company Name Region
Taiga Biotechnologies, Inc. United States
Sustained Release, Inc. United States
Edwards Environmental Corporation United States
Aseptica, Inc. United States
MBL International Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OvaScience, Inc., please visit www.ovascience.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.